← Back to Search

Other

Microfluidics chamber for Infertility

N/A
Waitlist Available
Led By Alison Bartolucci, PhD
Research Sponsored by Lawrence Engmann
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1-2 years after initial study completed
Awards & highlights

Study Summary

This trial tests if a device used to process sperm will help create healthier embryos during IVF treatment.

Eligible Conditions
  • Infertility
  • Miscarriage

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1-2 years after initial study completed
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1-2 years after initial study completed for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Euploidy rate of resulting embryos
Secondary outcome measures
Embryo transfer (procedure)
Other outcome measures
DNA fragmentation results

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: MicrofluidicsExperimental Treatment1 Intervention
Half of participants eggs will be injected with sperm processed using a microfluidics chamber.
Group II: Density gradient centrifugationActive Control1 Intervention
Half of participants eggs will be injected with sperm processed using a density gradient centrifugation (the standard method).

Find a Location

Who is running the clinical trial?

Lawrence EngmannLead Sponsor
The Center for Advanced Reproductive Services, P.C.OTHER
ZyMot FertilityUNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this clinical trial open to recruitment?

"The goal of this trial is to enroll 150 individuals between the ages 18 and 42 who are currently infertile. In addition, participants must be prepubescent female aged at least 18 years old or younger than 42."

Answered by AI

Does the age restriction for this experiment extend beyond 80 years?

"Participants aged between 18 and 42 years old may apply for this trial."

Answered by AI

Is this experiment inviting new participants?

"Reports on clinicaltrials.gov report that this medical trial, initially posted in January 2021 and last edited in September 2022, is not currently recruiting patients. Nevertheless, there are still 250 other studies searching for participants at the present moment."

Answered by AI

Who else is applying?

What state do they live in?
Utah
New York
How old are they?
18 - 65
What site did they apply to?
The Center for Advanced Reproductive Services
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Microfluidics Versus Gradient Centrifugation Effect on Euploidy Rates
Lawrence Engmann 2021. "Microfluidics Versus Gradient Centrifugation Effect on Euploidy Rates". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04744025.
~35 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top